ライフサイエンスコーパス: postpartum women

1 ession, including depression in pregnant and postpartum women.

2 or viral decline in a cohort of HCV-infected postpartum women.

3 ired ability to mount a boosting response in postpartum women.

4 ral adult population, including pregnant and postpartum women.

5 ive behavioral therapy (CBT) in pregnant and postpartum women.

6 ting ART use among HIV-infected pregnant and postpartum women.

7 ent and distressing symptoms in pregnant and postpartum women.

8 esearch gaps in tuberculosis in pregnant and postpartum women.

9 isk of psychiatric disorders in pregnant and postpartum women.

10 se events should be particularly targeted to postpartum women.

11 for those at 37-42 weeks in comparison with postpartum women.

12 of calcium supplementation (1 g per day) in postpartum women.

13 requently used as the baseline in studies of postpartum women.

14 les as did 5 of 97 army recruits and 2 of 50 postpartum women.

15 10 with major depression, 15 healthy) and 24 postpartum women (13 with major depression, 11 healthy).

16 significantly shorter than that observed in postpartum women (148 vs 256 h; P<.001), and the median

17 Among pregnant and postpartum women 18 years and older, 6 trials (n = 11,86

18 this quantity to be significantly reduced in postpartum women, 20.6+/-1.7 versus 26.1+/-2.0 mmHg in c

19 Postpartum women across all groups were less likely to b

20 Six hundred antenatal and postpartum women aged 18-39 y were randomized to an HIV

21 , 4, 6, 12, and 18 mo postparturition in 115 postpartum women aged 20-40 y (parity: 0-1).

22 sulfadoxine or pyrimethamine in prepartum or postpartum women, although partum status did have a sign

23 Among low-income postpartum women, an internet-based weight loss program

24 ses genital tract infections in pregnant and postpartum women and respiratory infections in neonates.

25 Data were reported for 94 pregnant women, 8 postpartum women, and 137 nonpregnant women of reproduct

26 cases of invasive GBS disease in pregnant or postpartum women, and 57000 (UR, 12000-104000) fetal inf

27 Postpartum women are at increased risk of developing pue

28 depression among Latina and African American postpartum women are similar to epidemiologic rates for

29 or-blind, clinical trial enrolling 371 adult postpartum women at 12 clinics in WIC programs from the

30 d bone turnover markers were measured in 115 postpartum women at 2 weeks, 2 months, 4 months, 6 month

31 s and acellular pertussis (Tdap) vaccine for postpartum women before hospital discharge.

32 disorder in many Latina and African American postpartum women begins before delivery, revealing the n

33 dy levels, and whether this was different in postpartum women compared with control women.

34 risk of stroke by age group in pregnant and postpartum women compared with their nonpregnant contemp

35 Two to four weeks postpartum, women completed a 91-item survey by telephon

36 s, and Children (WIC program) for low-income postpartum women could produce greater weight loss than

37 ss episodes among 8,323 healthy pregnant and postpartum women enrolled in a Puget Sound region, Washi

38 Ten to twenty percent of postpartum women experience anxiety or depressive disord

39 , including invasive disease in pregnant and postpartum women, fetal infection/stillbirth, and infant

40 (3) how to screen and diagnose pregnant and postpartum women for active and latent tuberculosis; (4)

41 idence suggested that screening pregnant and postpartum women for depression may reduce depressive sy

42 ding multiple HIV self-tests to pregnant and postpartum women for secondary distribution is more effe

43 r review of 17 cases of botulism in pregnant/postpartum women found that more than half required vent

44 in blood and residential tap water from 150 postpartum women from three U.S. locations.

45 Pituitaries from pregnant and postpartum women had a fivefold higher apoptotic index c

46 Postpartum women had reduced Plasmodium spp. antibody le

47 Past-year pregnant and postpartum women had significantly lower rates of alcoho

48 r among pregnant (HR 1.3, 95% CI 0.5-2.1) or postpartum women (HR 1.1, 95% CI 0.6-1.6) than among non

49 gle-large-dose vitamin A supplementation for postpartum women in areas of prevalent vitamin A deficie

50 95% CI 0.6-1.6) than among non-pregnant/non-postpartum women in five studies with available data.

51 s such as targeted screening of pregnant and postpartum women in high-risk groups should be evaluated

52 pective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided into der

53 sting and couples testing among pregnant and postpartum women in sub-Saharan Africa is essential for

54 To advance inclusion of pregnant and postpartum women in tuberculosis drug trials, the US Nat

55 Over 12 weeks, mean antibody levels in postpartum women increased to levels observed in control

56 ng the population (HIV-infected pregnant and postpartum women), intervention (ART), and outcomes of i

57 in a more diverse population of pregnant and postpartum women, like women with high risk pregnancies

58 different between lactating and nonlactating postpartum women matched for age, body weight, and adipo

59 Postpartum women may be microchimeric to offspring hemat

60 A total of 120 postpartum women meeting DSM-IV criteria for major depre

61 For pregnant and postpartum women, micronutrient supplementation should b

62 antly between unipolar depressed and healthy postpartum women or between bipolar and healthy subjects

63 ser but was consistent with the evidence for postpartum women regarding the benefits of screening, th

64 use severe illness and death in pregnant and postpartum women; regardless of the results of rapid ant

65 sed pregnant women but elevated in depressed postpartum women relative to matched healthy comparison

66 12 (80% [95% CI, 51.9%-95.7%]) pregnant and postpartum women, respectively (P > .99).

67 1 (73.3% [95% CI, 44.9%-92.2%]) pregnant and postpartum women, respectively (P = .03).

68 Five HIV(-) and 6 HIV(+) postpartum women returned 2-3 months after delivery for

69 RSA is an increasingly important pathogen in postpartum women; risk factors for postpartum SA breast

70 he annual incidence was 5 times higher among postpartum women than pregnant women (511.2 vs. 95.8 per

71 ons, including older adults and pregnant and postpartum women; the accuracy of depression screening i

72 died--nonpregnant women, pregnant women, and postpartum women (those who had delivered < or = 2 weeks

73 In all, 18 pregnant women and 4 postpartum women (total, 22 of 102 [22%]) required inten

74 ulative incidence of PAS per 100000 pregnant/postpartum women vs nonpregnancy-associated stroke (NPAS

75 o 24 years was 14 events per 100000 pregnant/postpartum women vs NPAS incidence of 6.4 per 100000 non

76 for venous thromboembolism among pregnant or postpartum women was 4.29 (95% CI, 3.49 to 5.22;P < 0.00

77 GFR in postpartum women was elevated above control values by 41

78 ibutable risks in comparable nonpregnant and postpartum women were 1.91 (95% CI 1.51-2.31) and 1.16 (

79 nts with postpartum psychosis and 64 healthy postpartum women were included.

80 At 2 wk postpartum, women were randomly assigned to receive eith

81 clinically relevant weight loss in lactating postpartum women, which was sustained at 9 mo after trea

82 gesterone replacement reduces cocaine use in postpartum women with a cocaine use disorder (CUD).

83 ort the promise of progesterone treatment in postpartum women with a CUD and could constitute a thera

84 Pregnant but not postpartum women with a personal or family history of de

85 the risks of disturbed sleep to pregnant and postpartum women with bipolar disorder, as well as struc

86 r, these levels were significantly higher in postpartum women with major depression across time inter

87 plasma melatonin differentiate pregnant and postpartum women with major depression from matched preg

88 This association was not found among postpartum women with major depression or postpartum hea

89 ally relevant and sustainable weight loss in postpartum women with overweight and obesity.

90 a racially and ethnically diverse cohort of postpartum women with recent GDM.

91 ults for the benefit of CBT for pregnant and postpartum women with screen-detected depression showed

92 fication treatment to produce weight loss in postpartum women within the primary health care setting

93 Controls were randomly selected postpartum women without VTE, matched on birth year.

94 Findings estimate that 20-43 pregnant/postpartum women would need to be vaccinated with an 80%

95 ing outcomes among HIV-infected pregnant and postpartum women, yet rates of initiation, adherence, an